Teva's total assets for Q2 2025 were $40.13B, an increase of 4.47% from the previous quarter. IL:TEVA total liabilities were $33.30B for the fiscal quarter, a 3.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.